Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
MyMD PHARMA'S PATHS TO SUCCESS
1. MyMD DEVELOPES WORLD'S 1ST 2nd GENERATION TNF-alpha MODULATOR.
2. LAB COMPARISONS OF MYMD-1 WITH 3 POPULAR JAK STAT BLOCKERS FINDS
IT TO BE EQUALLY EFFECTIVE, GIVING IT THE OPPORTUNITY TO GARNER
A PORTION OF THIS MARKET.
3. MyMD EXPECTS TO OFFER ALL HUMANS OVER THE AGE OF 64 THE OPPORTUNITY
TO LIVE LONGER, AND HEALTHIER WHILE DOING SO. IT ALSO SEES THE SAME
BENEFIT TO ALL OTHER MAMMALS WHO REACH COMPARABLE AGES.
MyMD PHARMA'S PATHS TO SUCCESS
1. MyMD DEVELOPES WORLD'S 1ST 2nd GENERATION TNF-alpha MODULATOR.
2. LAB COMPARISONS OF MYMD-1 WITH 3 POPULAR JAK STAT BLOCKERS FINDS
IT TO BE EQUALLY EFFECTIVE, GIVING IT THE OPPORTUNITY TO GARNER
A PORTION OF THIS MARKET.
3. MyMD EXPECTS TO OFFER ALL HUMANS OVER THE AGE OF 64 THE OPPORTUNITY
TO LIVE LONGER, AND HEALTHIER WHILE DOING SO. IT ALSO SEES THE SAME
BENEFIT TO ALL OTHER MAMMALS WHO REACH COMPARABLE AGES.
4. SOON MyMD WILL BE DOSING PATIENTS DIAGNOSED WITH COVID 19 INDUCED
DEPRESSION, WITH MYMD-1, A POWERFUL ANTI- DEPRESSANT. WHILE IT IS
EXPECTED TO BE EFFECTIVE, IT WILL ALSO DEMONSTRATE IF IT IS EFFECTIVE
AGAINST COVID-19 SIDE EFFECTS AND "LONG-HAULER" PROBLEMS.
5. ON AUG. 10, 2021 MyMD ANNOUNCED RECEIPT OF PATENT # 11,096,933
COVERING ITS SYNTHETIC CBD MOLECULE.
6. IF ALL ABOVE WAS NOT ENOUGH, ON AUG. 10, 2021 MyMD ANNOUNCED ITS
OWNERSHIP OF 13% OF THE STOCK OF ORAVAX MEDICAL, A COMPANY WHICH
HAS BEGUN THE 1ST TEST OF A COVID-19 VACCINE IN PILL FORM.
OOPS, wrong board !
What's with the nearly 6 million share BID at .0009 !!!!!
Price change and volume seem to be telling us something today!
Sorry Leif, but I have no idea if something can be done with the RCPIQ listing, but I sold off 1/2 of a significant position in RCPIQ, and am letting the rest go to zero or whatever only because the trading in RCPIQ didn't look normal, like today's.
We need the "SCIENCE" and that only comes with test results!
The recent news (8/10/21) of the Oravax vaccine in pill form soon to be tested on non-vaccinated citizens of Isreal to determine its effectiveness in producing antibodies was picked up by news agencies around the world.
A number of sources lauded the Oramed/Premas development as a breakthrough of blockbuster proportions, which has resulted in the Board of Directors of MyMD to consider spinning off their shares of Oravax to existing shareholders. Were this to be the case, if said spinoff were based on the current circumstances, MyMD (Florida) shareholders would receive 80% of those shares, and MyMD (Akers) 20%, while it was Akers that brought the Premas vaccine to the merger table.
This unfairness might require an adjustment in the normal spinoff procedure, for example allowing MyMD (Akers) shareholders to receive 1 share of Oravax for each 100 shares of MyMD owned, but only allowing MyMD (Florida) shareholders to receive 1 share of Oravax for each 400 shares of MyMD owned.
Yes, I'll believe it, but only when I see it!
Anyone care to comment on recent activity, like today when most of the volume was at the higher prices. One could explain that the volume was due to short covering, but why cover a stock that is going to zero!
Thinking maybe the field is much too crowded with so many companies competing, and some even pursuing a drug version.
It's looking like MYMD doesn't want the Oravax vaccine in pill form to distract the company from its current development, as it looks for ways to dispose of its Oravax shares!
https://ih.advfn.com/stock-market/NASDAQ/mymd-pharmaceuticals-MYMD/stock-news/85798740/mymd-pharmaceuticals-subsidiary-oravax-medical-pre
MYMD told us that the Phase 2 study of Covid 19 induced depression would begin in the 1st quarter of 2021! With the new variant running rampant, this would be an ideal time to begin this trial.
I acknowledge that MYMD knows what it is doing, but it sure is frustrating!
There has been no shortage of info about the tremendous potential for MyMD.
What we are lacking is the SCIENCE to bring it into the real world!
Something to read while waiting. Articles dated 3 July and 10 July.
https://choprafoundation.org/category/articles/page/36/
Something to look at during this endless waiting!
https://jonnierwilliamssr.com/
Saw a news blurb late yesterday to the effect that the FDA was now able to begin working on the significant backup that occurred as a result of the Covid focus!
Perhaps this might have affected MYMD's Phase 2 trials.
Does anyone here see any significance in the fact that the bulk of today's volume of 113k so far were "BUYS" of 52k, 44k, and 5k at .0013, .0016 and .0015. Why would anyone be buying under the circumstances!
What do we do with our RCPIQ now, bono!
What do we do with our RCPIQ now, bono!
Appreciate all you have contributed to this board which has few contributors, although all we have seen so far are indications that MYMD-1 may be a super medical breakthrough that will relieve billions of humans of countless medical conditions. The 2 human studies which were to occur in the 1st quarter of 2021 didn't occur, nor in the 2nd quarter. So here we are with MYMD-1 at $5.54 down .05 on 12,745 shares, unknown, unloved, and unfollowed!
liefsmith, you have given us a mountain of material to ponder here!
However, what has troubled me since I became a Star Scientific stockholder, before the infamous patent infringement tobacco trial, is that we have yet to see the 1st scientific evidence that the nicotinic molecules have any human medical benefits, as we have yet to see the results of a HUMAN trial.
Patents, patent claims, preclinical trials, and phenotypic studies are all just indications of what may be true, but human clinical trials are science that demonstrate was is reality, and we seem to be having difficulty getting that 1st HUMAN clinical trial result !!!!!
At age 88, and having purchased my 1st stock, Artloom Carpet, at age 17, I can say that I have never seen in those 71 years, a stock with this much seeming potential being totally ignored by Wall Street, financial media, and speculators, but I remain hopeful that I am seeing a "first" !!
Today's news release is an "in your face", "no holds barred" clear explanation of the superiority of MYMD'S MYMD-1 compared to several of the significant TNFa inhibitors in the market today! It also gives David Rimi, the latest addition to MYMD's Scientific Advisory Board, an opportunity to demonstrate what he can do as a medical illustrator, and it is mind blowing if you can enlarge it in color. Not easy !!!!!
In spite of this, the stock is acting as if a bomb hit it, which brings into question who is selling it, and why !!!!!
DR. Scott Freeman, one of the co-founders of MNMD has joined the Scientific Advisory Board of MYMD.
With volume at 1.3 million and price at .0012, it sure looks like Jonnie has abandoned us here at RCPIQ !!!!!
Sounds like ARPA-H would would be great for MyMD Pharma!
https://science.sciencemag.org/content/early/2021/06/22/science.abj8547
Was greatly surprised to see in the following linked article that brain inflammation may lead to Parkinson's Disease!
https://www.apdaparkinson.org/article/the-role-of-inflammation-in-parkinsons-disease/
Looks like Jonnie has too much else on his mind!
The $3.2 billion announced today to produce effective new antivirals should give a lift to MyMD's candidate in this area:
https://patents.justia.com/patent/10786493
WOW!!!!! Given today's 7.5% sprint on 4 times average daily volume, it sure looks like you are "right on"!!!!!
Sorry we don't yet have an active message board here, but given a continuance of this kind of performance, it won't be long in becoming one.
Much thanks for the info, Sean!
MYMD up strongly on a day when all major indices were down and NASDAQ down the most percentagewise! What is it trying to tell us!
Looking like the Bid and Ask prices are slowly drifting downward!
Read this link just out from Bloomberg (5/24/21 10/32/PM EDT) along with the link in message #67, and you can see why MyMD is starting with Covid induced depression as its 1st Phase 2 trial.
I believe they are looking for MYMD-1's ability to knock down inflammation and DEPRESSION along with it, to also have a strong impact on the accompanying "LONG COVID" problems. At any rate I am sure the FDA is following this very closely and is anxious to help!
https://www.washingtonpost.com/business/why-impact-of-long-covid-could-outlast-the-pandemic/2021/05/24/fbef4794-bcfc-11eb-922a-c40c9774bc48_story.html
The word is beginning to get around, and MyMD Pharma has the answer!
https://medicalxpress.com/news/2021-05-inflammation-core-feature-depression.html
Today's MYMD presentation delivered by Dr. Adam Kaplin was an "in your face", "no holds barred" challenge to the pharmaceutical industry that MyMD Pharmaceuticals was was coming on strong !!!!!
His performance just blew me away. !!!!!
SEAN
On a day when all of the major indices were significantly positive, MYMD went from an 11 o'clock high of $3.72 to a low of $3.35, closing at $3.39
with no bad news, but with a probably strong presentation to the Bezinga Conference and a strongly positive submission to the S.E.C. a couple of days before. Additionally, they will be presenting Monday on the internet, what I expect will be what they reported to the S.E.C.
MYMD's Friday performance was completely out of whack with the background market, looking like they had released bad news, or looking like someone was determined to push the price lower !!!
Somebody's putting the pressure on MYMD !!!!!